Oncogenic Kit Triggers Shp2/Erk1/2 Pathway to Down-Regulate the Pro-Apoptotic Protein Bim and to Promote Apoptosis Resistance in Leukemic Cells
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference28 articles.
1. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias;F Moreau-Gachelin;Mol Cell Biol,1996
2. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations;Y Ma;Blood,2002
3. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit;C Akin;Exp Hematol,2003
4. Cotargeting signaling pathways driving survival and cell cycle circumvents resistance to Kit inhibitors in leukemia;D Buet;Blood,2012
5. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity;SM Maira;Mol Cancer Ther,2008
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1;Cancer Gene Therapy;2022-04-21
2. SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis;Experimental Dermatology;2018-06
3. FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells;Oncology Reports;2017-12-01
4. Pim-2 protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via downregulation of Bim expression;Environmental Toxicology and Pharmacology;2016-12
5. Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance;Methods in Molecular Biology;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3